Hyperinfectivity in Cholera: A New Mechanism for an Old Epidemiological Model?
Author
Abstract
Suggested Citation
DOI: 10.1371/journal.pmed.0030280
Download full text from publisher
References listed on IDEAS
- Elizabeth A Almasi & Randall S Stafford & Richard L Kravitz & Peter R Mansfield, 2006. "What Are the Public Health Effects of Direct-to-Consumer Drug Advertising?," PLOS Medicine, Public Library of Science, vol. 3(3), pages 1-1, March.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Pepijn Pol & Frank Bakker, 2010. "Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?," Journal of Business Ethics, Springer, vol. 94(2), pages 211-224, June.
- Frosch, Dominick L. & May, Suepattra G. & Tietbohl, Caroline & Pagán, José A., 2011. "Living in the “land of no”? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs," Social Science & Medicine, Elsevier, vol. 73(7), pages 995-1002.
- Ram Bala & Pradeep Bhardwaj, 2010. "Detailing vs. Direct-to-Consumer Advertising in the Prescription Pharmaceutical Industry," Management Science, INFORMS, vol. 56(1), pages 148-160, January.
- Levaggi, Rosella & Orizio, Grazia & Domenighini, Serena & Bressanelli, Maura & Schulz, Peter J. & Zani, Claudia & Caimi, Luigi & Gelatti, Umberto, 2009. "Marketing and pricing strategies of online pharmacies," Health Policy, Elsevier, vol. 92(2-3), pages 187-196, October.
- Paul Biegler, 2014. "Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising," Journal of Business Ethics, Springer, vol. 123(1), pages 145-155, August.
- Guy David & Sara Markowitz & Seth Richards-Shubik, 2010.
"The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation,"
American Economic Journal: Economic Policy, American Economic Association, vol. 2(4), pages 1-25, November.
- Guy David & Sara Markowitz & Seth Richards, 2009. "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation," NBER Working Papers 14634, National Bureau of Economic Research, Inc.
- Keith J. Zullig & Amanda L. Divin, 2022. "Quantifying Healthy Days Lost to the Non-Medical Use of Prescription Drugs (NMUPD) among a Sample of College Students," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 17(2), pages 655-669, April.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:0030280. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.